Comparative Effectiveness of Ampicillin/Sulbactam versus Cefazolin as Targeted Therapy for Bacteremia Caused by Beta-Lactamase-Producing Methicillin-Sensitive Staphylococcus aureus: A Single-Center Retrospective Study

Cefazolin (CFZ) is the first-line treatment for beta-lactamase-producing methicillin-sensitive Staphylococcus aureus (BP-MSSA) infection. In 2019, Japan experienced a CFZ shortage because of foreign object inclusion in a batch. Ampicillin/sulbactam (SAM) was preferred in many cases as definitive the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirai, Jun, Asai, Nobuhiro, Hagihara, Mao, Kishino, Takaaki, Kato, Hideo, Sakanashi, Daisuke, Ohashi, Wataru, Mikamo, Hiroshige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686817/
https://www.ncbi.nlm.nih.gov/pubmed/36358161
http://dx.doi.org/10.3390/antibiotics11111505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686817/
https://www.ncbi.nlm.nih.gov/pubmed/36358161
http://dx.doi.org/10.3390/antibiotics11111505

Ejemplares similares